Vaccines for HIV/AIDS Prevention: Findings
Findings, 2000 - Present
- Virus Used to Transport HIV Vaccine Into Body May Be Behind Failure, Study Suggests (November 17, 2009)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Brief Shocks May Deliver AIDS Vaccines Better: Study (October 23, 2009)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- AFP Examines Recent HIV Vaccine Findings (October 22, 2009)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Media Outlets Examine How AIDS Vaccine Trial Results Will Shape Future Studies (October 21, 2009)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- As HIV Vaccine Conference Opens, Experts Appeal for Sustained Commitment to Global Fight Against Disease (October 20, 2009)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Anticipating the Results of the Phase III Vaccine Trial in Thailand (PDF) (September 2009)
Preparing for results from the ALVAC-AIDSVAX
Prime-Boost vaccine trial.
From AIDS Vaccine Advocacy Coalition
- AVAC Praises Thai AIDS Vaccine Trial Collaborators and Volunteers for Historic Study (September 24, 2009)
To read PDF, click here
From AIDS Vaccine Advocacy Coalition
- Frequently Asked Questions Regarding the RV144 Phase III HIV Vaccine Trial (September 24, 2009)
To read PDF, click here
From U.S. Military HIV Research Program
- HIV Vaccine Regimen Demonstrates Modest Preventive Effect in Thailand Clinical Study (September 24, 2009)
From U.S. National Institute of Allergy and Infectious Diseases
- HIV Vaccine Study First to Show Some Effectiveness in Preventing HIV (September 24, 2009)
To read PDF, click here
From U.S. Military HIV Research Program
- Investigational Vaccine Shows Modest Potential for Protecting Against HIV Infection (September 24, 2009)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- RV144 Phase III HIV Vaccine Trial (September 24, 2009)
U.S. Army and the Thailand Ministry of Public Health join forces to develop a safe and effective preventive HIV vaccine.
To read PDF, click here
From U.S. Military HIV Research Program
- Prevention, Vaccines Addressed at IAS Conference (July 22, 2009)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Researchers Develop Vaccine Candidate That Is Successful in Blocking Simian Version of HIV (May 18, 2009)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- AIDS Vaccine Research and Advocacy: An Update (Winter/Spring 2009)
To read PDF, click here
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
- Duke Scientists Find Rare, Potent Antibody to HIV-1 (February 23, 2009)
From Duke Medicine
- HIV Vaccine Development in 2009: Looking Back (and Forward) (February 11, 2009)
Mitchell Warren, the top dog at the AIDS Vaccine Advocacy Coalition, talks about the current state of vaccine development. He explains why, in his opinion, hope on the vaccine front is far from lost.
In The 16th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- AIDS Vaccine Update: Questions After Candidate Fails in the STEP Study (April 2008)
To read PDF, click here
In GMHC Treatment Issues, from Gay Men's Health Crisis
- Summit on HIV Vaccine Research and Development (March 25, 2008)
This is a webcast of the meeting.
From U.S. National Institute of Allergy and Infectious Diseases
- The Failed HIV Vaccine, the HPV Vaccine Hullabaloo and the Future of HIV Prevention (January 2008)
To read PDF, click here
In HHS Watch, from Community HIV/AIDS Mobilization Project
- Merck HIV Vaccine Trial Results: Hopes Dim for Struggling Field (Winter 2008)
To read PDF, click here
In TAGline, from Treatment Action Group
- Leaders of Merck's Canceled HIV Vaccine Study Notify Participants Whether They Received Vaccine, Placebo (November 14, 2007)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Merck Halts International HIV Vaccine Trial (September 24, 2007)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Vaccination and Enrollment Are Discontinued in Phase II Trials of Merck's Investigational HIV Vaccine Candidate (September 21, 2007)
From Merck & Co., Inc.
- Predicting the Impact of a Partially Effective HIV Vaccine and Subsequent Risk Behavior Change on the Heterosexual HIV Epidemic in Low- and Middle-Income Countries: A South African Example (September 1, 2007)
In Journal of Acquired Immune Deficiency Syndromes
- AIDS Vaccine Update (July-December 2007)
Disappointment and questions after candidate fails in the STEP study.
In GMHC Treatment Issues, from Gay Men's Health Crisis
- Male Circumcision Reduces Men's HIV Infection Risk by 65%, Data Re-Evaluation Says (February 23, 2007)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Scientists Unveil Piece of HIV Protein That May Be Key to AIDS Vaccine Development (February 14, 2007)
From U.S. National Institute of Allergy and Infectious Diseases
- VAX Primer: Understanding the Early Stages of HIV Infection (April 2006)
How can studying what happens immediately following HIV infection help researchers design an AIDS vaccine?.
From International AIDS Vaccine Initiative
- Enrolling Women Into HIV Preventive Vaccine Trials: An Ethical Imperative but a Logistical Challenge (February 21, 2006)
In PLoS Medicine
- HIV Vaccine's CD4+ Cell-Boosting Properties Lead Merck to Double Enrollment in Study (September 23, 2005)
[Archived Article]
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Most in U.S. Hopeful About Development of HIV Vaccine, but Many Fear Participation in Trials, Study Shows (August 9, 2005)
[Archived Article]
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- A Promising Alternative: Preclinical Assessment of HIV Vaccines and Microbicides by Repeated Low-Dose Virus Challenges (August 2005)
[Archived Article]
A study by researchers at Emory University and Merck.
In PLoS Medicine
- Phase I Trial of Italian HIV Vaccine Trial Successful, Researchers Say; Phase II To Test Vaccine in Africa (July 7, 2005)
[Archived Article]
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Health Affairs Focuses on Vaccines, Features Interview With Thompson; Kaiser Family Foundation Describes Media Campaigns (May 12, 2005)
[Archived Article]
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- International AIDS Vaccine Initiative Releases Several Working Papers, Brief (April 26, 2005)
[Archived Article]
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Treble Damages: Three Highlighted Studies From the AIDS Vaccine 2004 Conference (October 2004)
[Archived Article]
Disappointment clouded this year's conference, with new study results suggesting that current approaches to vaccine development aren't panning out.
In TAGline, from Treatment Action Group
- Slow but Real Progress on the AIDS Vaccine Front (September 3, 2004)
[Archived Article]
Highlights from the AIDS Vaccine 04 conference.
From aidsmap.com
- Researchers Identify Mutations That Help HIV Avoid Immune Detection; Implications for Vaccine Development (June 2, 2004)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Keystone HIV Pathogenesis and Vaccine Development Report (May/June 2004)
[Archived Article]
Highlights from the Keystone Symposia on Molecular Mechanisms of HIV Pathogenesis (X7) and HIV Vaccine Development (X8), April 12-18, 2004.
In GMHC Treatment Issues, from Gay Men's Health Crisis
- HIV More Vulnerable to Vaccine During Acute Infection, Study Suggests (March 26, 2004)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Scientists Find HIV-Blocking Protein in Monkeys (February 25, 2004)
[Archived Article]
TRIM5-alpha is the first host protein found that specifically targets HIV's capsid.
From U.S. National Institute of Allergy and Infectious Diseases
- Researcher Loses HIV Vaccine Data in Durban Mugging (August 6, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Antibody Discovery Could Lead to HIV Vaccine: Study (July 2, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- New HIV Vaccine Shows Promising Results in Preclinical Studies (June 4, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Nabbing the V3 Loop (May 2003)
[Archived Article]
Susan Zolla-Pazner offers new insight into why some anti-V3 loop antibodies have broad HIV neutralizing ability.
In TAGline, from Treatment Action Group
- Starting Anew (Again) (April 2003)
[Archived Article]
CROI 2003 updates on vaccines, siRNA therapy, CEM15 deactivation and the therapeutic value of GBV-C.
In IAPAC Monthly, from International Association of Physicians in AIDS Care
- AIDS Groups Call for Review of AIDS Vaccine Trial Results (March 31, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- HIV's Ability to Rapidly Evolve Occurs Quicker Than Thought (March 21, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Virion-Based Vaccine Protects Macaques Against SIV (March 19, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- First AIDS Vaccine Tested Did Not Protect, But Gives Scientific Leads (March 14, 2003)
[Archived Article]
In AIDS Treatment News, from AIDS Treatment News
- Stirring Up Racial Concerns (March 3, 2003)
[Archived Article]
The media comes under fire for overplaying AIDSVAX's poor study results, and underplaying its possible effectiveness in some minorities.
In San Francisco Chronicle
- AIDSVAX Arbitrary and Post-Hoc Subset Analysis, Up Close (March 2003)
[Archived Article]
In TAGline, from Treatment Action Group
- The VaxGen Study (Spring 2003)
[Archived Article]
In STEP Perspective, from Seattle Treatment Education Project
- Effectiveness of AIDS Vaccine May Be Overstated, Expert Says; Statistics Problem May Account for AIDSVAX Discrepancy (February 27, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Controversial HIV Vaccine Trial Results Disappointing (February 25, 2003)
[Archived Article]
From Canadian AIDS Treatment Information Exchange
- Official Hopes to Explain AIDS Vaccine Disparities (February 25, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- First AIDS Vaccine in Large Test Found to Be Mostly Ineffective (February 24, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- NPR Reports on AIDSVAX Trial Results (RealAudio) (February 24, 2003)
[Archived Article]
From National Public Radio
- Experiment Shows AIDS Vaccine Unlikely to Give Total Protection From Disease (February 13, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Experimental AIDS Vaccine Being Tested on Humans (January 27, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Willingness to Participate and Enroll in a Phase 3 Preventive HIV-1 Vaccine Trial (December 23, 2002)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- VaxGen's AIDS Vaccine to Be Reviewed by FDA (December 17, 2002)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- HIV Trick Helps Explain Failed Vaccine Attempts (December 13, 2002)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Research From the 42nd ICAAC: Alpha-Defensins, Non-Progressors and Vaccines (December 2002)
[Archived Article]
In IAPAC Monthly, from International Association of Physicians in AIDS Care
- HIV's Success Might Lie in Its Mutations (November 6, 2002)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- St. Louisan with HIV Is Fighting Off AIDS (September 25, 2002)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Researchers Document Rare Case of Second HIV Infection With Different Strain (September 5, 2002)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Expert Opinion From Barcelona: Vaccines (September/October 2002)
[Archived Article]
In Positively Aware, from Test Positive Aware Network
- HIV-Specific CD8 T-Cell Activity in Uninfected Injection Drug Users Is Associated With Maintenance of Seronegativity (August 26, 2002)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- HIV-1 Superinfection: AE Subtype Supplanted by B Subtype (July 11, 2002)
[Archived Article]
In The XIV International AIDS Conference, from The Body PRO
- Hope for AIDS Vaccine Fades; News of Superinfection Case (July 11, 2002)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Harnessing the Immune System to Fight HIV (July 10, 2002)
[Archived Article]
In The XIV International AIDS Conference, from The Body PRO
- Immune Responses in Long-Term Non-Progressors -- Lessons for Immune Reconstitution (July 10, 2002)
[Archived Article]
In The XIV International AIDS Conference, from The Body PRO
- Sign of HIV Immunity Reported; Protective Responses Suspected in Two Studies (July 10, 2002)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- HIV Selectively Suppresses Anti-HIV Defense Cells (May 1, 2002)
[Archived Article]
From U.S. National Institute of Allergy and Infectious Diseases
- Chimp Adenovirus as New Vaccine Vector (April 9, 2002)
[Archived Article]
Updates from Retrovirus 2002.
In TAGline, from Treatment Action Group
- Franchini's DNA Prime and NYVAC Boost Vaccine (April 9, 2002)
[Archived Article]
Updates from Retrovirus 2002.
In TAGline, from Treatment Action Group
- Not to Be Sneezed At: Merck's HIV Vaccine Program (April 9, 2002)
[Archived Article]
Updates from Retrovirus 2002.
In TAGline, from Treatment Action Group
- AIDS Vaccine Moves Ahead in Trials (April 5, 2002)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Effective AIDS Vaccine Probably at Least a Decade Away, Researcher Says (March 18, 2002)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- The Impact of Partially Effective HIV Vaccine on a Population of Intravenous Drug Users in Bangkok, Thailand: A Dynamic Model (March 7, 2002)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- The Promise of New Vaccine Vectors, the Perils of Partial Protection (March 1, 2002)
[Archived Article]
Two new HIV vaccine studies published in the journal Nature.
In TAGline, from Treatment Action Group
- Riddle Women: Reports of Progress Toward Understanding How Some People Appear to Fight Off HIV (November 2001)
[Archived Article]
In TAGline, from Treatment Action Group
- Vaccine Stops Vaginal Transmission of HIV-Like Virus (July 23, 2001)
[Archived Article]
From Reuters Health
- Simian Success (January 2001)
[Archived Article]
Vaccine study seen as significant advance, but questions remain about human applicability.
In TAGline, from Treatment Action Group
- Status Report on HIV Vaccine Development (Winter 2000)
[Archived Article]
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
- Vaccine Advance: Monkeys Still Infected, but Protected from Illness (October 20, 2000)
[Archived Article]
In AIDS Treatment News, from AIDS Treatment News
- New Finding on Immune Response to HIV Tat May Contribute to Vaccine, Treatment (September 22, 2000)
[Archived Article]
A study in monkeys has provided important information on how the immune response to HIV develops, why it is usually not sufficient, and how vaccine approaches might be tested more effectively in the future.
In AIDS Treatment News, from AIDS Treatment News
- Promising HIV Vaccine Strategy Identified in Monkey Studies (September 20, 2000)
[Archived Article]
From U.S. National Institute of Allergy and Infectious Diseases
- Vaccine Notes from the Cent Gardes (January 2000)
[Archived Article]
In TAGline, from Treatment Action Group
1999
- Silent Soldiers -- The AIDSVAX Army (September/October 1999)
[Archived Article]
One man's enlistment into the new era of AIDS activism.
In Positively Aware, from Test Positive Aware Network
- Economics of AIDS Vaccines (August 30, 1999)
[Archived Article]
From International AIDS Economics Network (IAEN)
- Combination HIV Vaccine Induces Diverse Immune Responses (July 13, 1999)
[Archived Article]
From U.S. National Institute of Allergy and Infectious Diseases
- NIH Dedicates New Vaccine Research Center to Dale and Betty Bumpers (June 9, 1999)
[Archived Article]
From U.S. National Institutes of Health
- HIV Antibody Breakthrough in Transgenic Mice Could Prove Boon to Vaccine Effort (June 1999)
[Archived Article]
From Treatment Action Group
- REMUNE Trial Will Stop; New Trials Planned (May 21, 1999)
[Archived Article]
From AIDS Treatment News
- Status of AIDS Vaccine Research at the National Institutes of Health (NIH) (May 18, 1999)
[Archived Article]
From U.S. National Institute of Allergy and Infectious Diseases
- Second Annual AIDS Vaccine Day Honors Volunteers Nationwide (May 13, 1999)
[Archived Article]
From U.S. National Institute of Allergy and Infectious Diseases
- Gates Foundation Donates $25 Million for AIDS Vaccine (May 7, 1999)
[Archived Article]
From AIDS Treatment News
- U.S. Vaccine Trial: New Email List (May 7, 1999)
[Archived Article]
From AIDS Treatment News
- The Role of CD8+ Lymphocytes in the Control of SIV Viremia (April 21, 1999)
[Archived Article]
By Jeffrey T. Safrit, Ph.D.
From U.S. National Institute of Allergy and Infectious Diseases
- AIDSVax Field Trial Makes a Splash While Humble Canarypox Phase II Plods Along Uncelebrated (March 1999)
[Archived Article]
From Treatment Action Group
- Breakthrough in AIDS Vaccine Development (March 1999)
[Archived Article]
In Body Positive, from Body Positive
- Status of Current HIV-1 Vaccine Strategies (Table) (March 1999)
[Archived Article]
From Treatment Action Group
- NIAID Opens First AIDS Vaccine Trial in Africa (February 8, 1999)
[Archived Article]
From U.S. National Institute of Allergy and Infectious Diseases
- New Studies Offer Clues to AIDS Vaccine Design and Safety (February 1, 1999)
[Archived Article]
From U.S. National Institute of Allergy and Infectious Diseases
1998
- Major Vaccine Project: Largest AIDS Research Grants Ever to Two "Most Promising" Approaches (December 4, 1998)
[Archived Article]
From AIDS Treatment News
- Stimulating Vaccine Development: The First Annual Conference on Vaccine Research (November 1998)
[Archived Article]
In Journal of the International Association of Physicians in AIDS Care, from International Association of Physicians in AIDS Care
- AmFAR RFPs: Immune Reconstitution, HIV Vaccines (October 16, 1998)
[Archived Article]
From AIDS Treatment News
- Chat with an AIDSVAX Volunteer (October 1998)
[Archived Article]
Nina Marks talks to Bert DaFonte, in Positive Living newsletter.
In Positive Living, from AIDS Project Los Angeles
- Large HIV Vaccine Trial Begins (October 1998)
[Archived Article]
In GMHC Treatment Issues, from Gay Men's Health Crisis
- Treatment News: Looking at AIDSVAX and Other Vaccine Trials (October, 1998)
[Archived Article]
By Nina Marks, in Positive Living newsletter.
In Positive Living, from AIDS Project Los Angeles
- AIDS Research: NIH Concocts a Booster Shot for HIV Vaccines (August 28, 1998)
[Archived Article]
By Jon Cohen, from Science magazine.
In Science
- One Part Aged Innovation, Two Parts Hubris: Is Remune Merely Reheated '93 Berlin Fare? (August/September 1998)
[Archived Article]
From Treatment Action Group
- HIV-Specific Immune Responses Restored by HIV Immunogen (July 10, 1998)
[Archived Article]
From AIDS Treatment News
- Jubilation, and Skepticism, Greet Announcement of First Phase III Trial of an AIDS Vaccine (July 1998)
[Archived Article]
From Treatment Action Group
- Vaccine Approaches Currently In Development (July 1998)
[Archived Article]
In Body Positive, from Body Positive
- Body & Soul: Unsung AIDS Advance (June 23, 1998)
[Archived Article]
One vaccine breakthrough overshadows another.
In The Village Voice
- Agouron and Immune Response to Commercialize Remune™ Immune-Based Treatment (June 22, 1998)
[Archived Article]
From AIDS Treatment News
- AIDS Vaccine: Major Report Available (May 15, 1998)
[Archived Article]
In AIDS Treatment News, from AIDS Treatment News
- Nine Years and Counting: Will We Have an HIV Vaccine by 2007? (May 1998)
[Archived Article]
An Agenda for Action for an HIV Vaccine.
From AIDS Vaccine Advocacy Coalition
- First Human Trial Shows that an Edible Vaccine is Feasible (April 27, 1998)
[Archived Article]
From U.S. National Institute of Allergy and Infectious Diseases
- David Gold Speaks Out on the Need for an HIV Vaccine (March 1998)
[Archived Article]
In Body Positive, from Body Positive
- Novel Concepts Put to the Test in Three New AIDS Vaccine Trials (January 29, 1998)
[Archived Article]
From U.S. National Institute of Allergy and Infectious Diseases
- The Debate Over How to Proceed with Vaccine Development Efforts (January 1998)
[Archived Article]
From Treatment Action Group
1997
- Heavy Volunteer Response to Possible Experimental Vaccine (November 1997)
[Archived Article]
In Body Positive, from Body Positive
- IAPAC's Editorial (November 1997)
[Archived Article]
Proposed human safety trial of a live-attenuated HIV vaccine raises ethical questions.
In Journal of the International Association of Physicians in AIDS Care, from International Association of Physicians in AIDS Care
- Fifty Volunteer for Live-Vaccine Trial (October 3, 1997)
[Archived Article]
In AIDS Treatment News, from AIDS Treatment News
- Update On HIV Vaccines (August 18, 1997)
[Archived Article]
In STEP Perspective, from Seattle Treatment Education Project
- IAPAC Challenges Physicians, Advocates to Volunteer for AIDS Vaccine Trial (August 1997)
[Archived Article]
From International Association of Physicians in AIDS Care
- IAPAC's Editorial (August 1997)
[Archived Article]
On a Physician-Volunteer Initiative for Live-Attenuated Vaccine Trials.
In Journal of the International Association of Physicians in AIDS Care, from International Association of Physicians in AIDS Care
- The State of the Art: HIV Vaccines (Summer 1997)
[Archived Article]
In The Direct Information on Research and Treatment Newsletter, from ARIC
- AIDS Action Welcomes President Clinton's Call for HIV Preventative Vaccine in Next Decade (May 18, 1997)
[Archived Article]
From AIDS Action Council
- Challenges in Designing HIV Vaccines (May 1997)
[Archived Article]
From U.S. National Institute of Allergy and Infectious Diseases
- Clinical Research on HIV/AIDS Vaccines (May 1997)
[Archived Article]
From U.S. National Institute of Allergy and Infectious Diseases
- HIV Vaccines Need to Be Developed: Interview with Sam Avrett, International AIDS Vaccine Initiative (May 1, 1997)
[Archived Article]
From AIDS Treatment News
- AIDS Vaccine Panel Discussion at the Meeting of the Presidential Advisory Council on HIV and AIDS (April 7, 1997)
[Archived Article]
From Harvard AIDS Institute
- AmFAR Awards More Than $800,000 in New Research Grants Including Novel Vaccine and Treatment Studies (February 1997)
[Archived Article]
From amfAR, The Foundation for AIDS Research
- Challenges in Designing HIV Vaccines (January 1997)
[Archived Article]
From U.S. National Institute of Allergy and Infectious Diseases
1996
- Vaccine Report Available (December 20, 1996)
[Archived Article]
In AIDS Treatment News, from AIDS Treatment News
- Honing the Immune Attack on HIV (December 1996)
[Archived Article]
Research on therapeutic vaccines.
In GMHC Treatment Issues, from Gay Men's Health Crisis
- Industry Investment in HIV Vaccine Research (December 1996)
[Archived Article]
In Industry Investment in HIV Vaccine Research, from AIDS Vaccine Advocacy Coalition
- rGP-160 Treatment Vaccine (VaxSyn): Canadian Study Finds No Benefit (April 19, 1996)
[Archived Article]
In AIDS Treatment News, from AIDS Treatment News
- Long-term Non-Progressors May Hold Clue to Vaccine (April 1996)
[Archived Article]
In HIV Newsline, from San Francisco General Hospital
- Slow Progress On HIV Vaccines (April 1996)
[Archived Article]
In GMHC Treatment Issues, from Gay Men's Health Crisis
- New Anti-HIV Vaccine and KS Trials at the National Cancer Institute (February 1996)
[Archived Article]
By Robert Yarchoan, M.D., Chief, Retroviral Diseases Section, MB, DCS.
From National Cancer Institute
1995
|
|
Advertisement
|
E-Mail
Glossary
Share
